Myomo (MYO) Research & Development (2016 - 2025)
Myomo (MYO) reported Research & Development of $1.5 million for Q3 2025, up 22.32% on a YoY basis from $1.2 million in Q3 2024, and down 23.67% quarter-over-quarter from $2.0 million in Q2 2025.
Myomo (MYO) Research & Development (2016 - 2025) Analysis & Trends
Myomo has reported Research & Development for 10 years, with the latest figure at $1.5 million in Q3 2025.
- For the quarter ending Q3 2025, Research & Development rose 22.32% year-over-year to $1.5 million; the trailing twelve-month figure through Sep 2025 stood at $6.9 million (up 68.17% YoY), and the FY2024 full-year result was $4.8 million, up 81.0% from the prior year.
- Research & Development for Q3 2025 stood at $1.5 million, down from $2.0 million in the prior quarter.
- The five-year high for Research & Development was $2.0 million in Q2 2025, with the low at $476991.0 in Q1 2023.
- Historically, Research & Development has averaged $934997.1 across 5 years, with a median of $717256.0 in 2023.
- Annual changes were most pronounced in 2022 — Research & Development slumped 36.56% — and 2024, when it soared 100.47%.
- Myomo's Research & Development stood at $787628.0 in 2021, then plunged by 36.56% to $499674.0 in 2022, then soared by 75.72% to $878007.0 in 2023, then soared by 77.64% to $1.6 million in 2024, then fell by 2.05% to $1.5 million in 2025.
- The last three Research & Development figures came in at $1.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.8 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 956,215.00 |
| Dec 31, 2023 | 878,007.00 |
| Sep 30, 2023 | 717,256.00 |
| Jun 30, 2023 | 564,235.00 |
| Mar 31, 2023 | 476,991.00 |
| Dec 31, 2022 | 499,674.00 |
| Sep 30, 2022 | 690,407.00 |
| Jun 30, 2022 | 632,872.00 |
| Mar 31, 2022 | 659,536.00 |
| Dec 31, 2021 | 787,628.00 |
| Sep 30, 2021 | 641,228.00 |
| Jun 30, 2021 | 600,116.00 |
| Mar 31, 2021 | 525,967.00 |
| Dec 31, 2020 | 418,758.00 |